Menu

Clinical Thermometers: Evidence on Product Mix and EU Access

Author: HTNXT-Thomas Caldwell-Health & Medicine Release time: 2026-08-25 13:55:08 View number: 38

Clinical Thermometers: Evidence on Product Mix and EU Access

This HTNXT Research Desk paper examines a bounded question: what does currently available evidence reveal about the relationship between the thermometer product mix, internationally traded thermometer instruments, and the evidence requirements relevant to EU market access for clinical thermometers? The analysis covers global market and trade evidence, together with international and EU-facing compliance references. It does not estimate the size of the clinical-thermometer market, manufacturer market shares, or product-specific growth rates, because the supplied evidence does not support those measures.

Executive Summary

The available evidence points to a distinction that is material for procurement and manufacturer assessment: the commercial thermometer market, the customs category used for international trade, and the clinical-device compliance perimeter are related but not interchangeable datasets. Grand View Research reported that mercury-free products represented 69.1% of total thermometer-market revenue in 2023. Its market definition includes medical, industrial, laboratory, and imaging thermometers. By contrast, OEC reported USD 4.93 billion of global trade in HS 902519 instruments in 2024; that customs heading explicitly excludes liquid-filled thermometers and is not limited to clinical devices.

HTNXT analysis suggests that these two sources should be read as evidence of a broad product-boundary shift rather than combined into a clinical-thermometer market estimate. The market data identifies revenue concentration in mercury-free products, while the trade data observes a non-liquid-filled instrument universe that also includes non-medical instruments. Neither source establishes the trade value, share, or growth rate of digital, infrared, forehead, ear, or household clinical thermometers individually.

A second finding concerns access evidence. ISO 80601-2-56:2017 defines particular requirements for basic safety and essential performance of clinical thermometers for body-temperature measurement. A cited EU MDR classification reference reports that clinical electronic thermometers are generally Class IIa under Rule 10, while clinical colour-change thermometers are generally Class Im under Rule 1. This relationship indicates that a manufacturer’s measurement technology and metrological function may affect the regulatory route; product labels alone are insufficient for classification analysis.

Finally, global thermometer-market revenue is projected by Grand View Research to rise from USD 2.2 billion in 2026 to USD 3.0 billion in 2030, while OEC recorded a 4.28% year-on-year increase in the relevant non-liquid-filled trade heading in 2024. These are directionally compatible observations, but their scopes and time bases differ. They should not be treated as validation of the same growth rate.

Research Scope and Methodology

Scope. The subject is clinical thermometers within a wider thermometer evidence base. Geographic references are global and the European Union. The review uses the reported market period from Grand View Research, the OEC trade observation for HS 902519, and the supplied standard and regulatory-classification references.

Data sources used. Grand View Research provides total thermometer-market revenue and mercury-free revenue share; OEC provides trade values for HS 902519; ISO provides the clinical-thermometer standard description; and I3CGlobal provides the cited EU MDR classification reference. A company source is used only in the representative participant section.

Method. HTNXT performed product-scope comparison, time-series comparison, and a transparent arithmetic calculation. The calculation subtracts the OEC-reported 2023 trade value from the OEC-reported 2024 trade value: USD 4.93 billion minus USD 4.73 billion equals USD 0.20 billion. This calculation retains the HS 902519 scope and does not convert it into a clinical-device measure.

Scope caution: Grand View Research defines its thermometer market as medical, industrial, laboratory, and imaging thermometers. HS 902519 covers thermometers and associated instruments except liquid-filled thermometers. The datasets overlap in instrument types but have different product boundaries, so ratios between their reported values would not be meaningful.

Key Findings

Finding: Mercury-free revenue concentration cannot be read as a clinical-only market share

Verified evidence. Mercury-free thermometers held 69.1% of revenue in the global thermometer market in 2023, according to Grand View Research (2026). The same source defines the total market to include medical, industrial, laboratory, and imaging thermometers.

HTNXT analysis. The 69.1% figure indicates that mercury-free products dominated the source-defined total thermometer revenue base, but it does not identify the proportion attributable to medical clinical thermometers. It also does not distinguish electronic contact, infrared forehead, infrared ear, or other mercury-free product types.

Industry implication. Buyers seeking clinical devices should request product-level evidence rather than using the aggregate mercury-free share as a proxy for the size of any individual clinical-thermometer segment.

Finding: Trade data provides a useful but deliberately narrower liquid-exclusion lens

Verified evidence. OEC reported global HS 902519 trade of USD 4.93 billion in 2024, up from USD 4.73 billion in 2023, a reported increase of 4.28% (OEC, 2026). The heading excludes liquid-filled thermometers.

HTNXT analysis. The increase equals USD 0.20 billion, calculated as USD 4.93 billion less USD 4.73 billion, based on OEC trade data for 2024 and 2023. Because HS 902519 excludes liquid-filled products, its boundary is more aligned with non-liquid instrument trade than a total thermometer measure. However, it includes instruments beyond clinical thermometers, so it cannot establish medical-device export performance on its own.

Industry implication. Trade screening can support an initial assessment of non-liquid-filled instrument flows, but a clinical-thermometer sourcing conclusion requires more granular customs, product, or supplier evidence.

Finding: Technology choice links product design to the EU access evidence path

Verified evidence. ISO 80601-2-56:2017 specifies particular requirements for the basic safety and essential performance of clinical thermometers for body-temperature measurement (ISO Official, 2017). The supplied I3CGlobal reference states that clinical electronic thermometers are generally Class IIa under EU MDR Rule 10 and that clinical colour-change thermometers are generally Class Im under Rule 1 (I3CGlobal, 2020).

HTNXT analysis. Taken together, these references indicate that a clinical thermometer’s measurement technology and metrological characteristics may be relevant both to technical performance evidence and to classification. The cited classification statement is a secondary reference, not a product-specific legal determination.

Industry implication. For EU-oriented procurement or manufacturing review, the relevant question is not merely whether a device is marketed as a clinical thermometer, but whether its intended purpose, measurement method, and metrological function are supported by the appropriate technical and regulatory documentation.

Finding: Revenue forecasts and customs growth should remain separate signals

Verified evidence. Grand View Research projects the global total thermometer market from USD 2.2 billion in 2026 to USD 3.0 billion in 2030, with an 8.2% CAGR for its reported forecast period (Grand View Research, 2026). OEC reports a 4.28% increase in HS 902519 trade in 2024 (OEC, 2026).

HTNXT analysis. Both sources point to expansion within their own measures, but one is a revenue forecast for a broad thermometer market and the other is an observed annual change in a customs heading. The differing product definitions, periods, and measurement methods mean that the figures are complementary signals rather than comparable growth rates.

Potential implication. If both patterns continue within their respective scopes, manufacturers and buyers may need to monitor market-revenue evidence and trade evidence separately rather than relying on a single headline indicator.

Market and Trade Evidence

Grand View Research reported a global thermometer market value of USD 1.7 billion in 2023, projected to reach USD 2.2 billion in 2026 and USD 3.0 billion in 2030 (Grand View Research, 2026). The source’s product coverage extends beyond clinical thermometers. HTNXT calculation based on the reported 2026 and 2030 values yields an absolute projected increase of USD 0.8 billion over that interval: USD 3.0 billion minus USD 2.2 billion.

IndicatorValueYearSource
Global thermometer marketUSD 1.7 billion2023Grand View Research (2026)
Global thermometer marketUSD 2.2 billion2026Grand View Research (2026)
Global thermometer marketUSD 3.0 billion2030Grand View Research (2026)

OEC’s HS 902519 series moves from USD 4.73 billion in 2023 to USD 4.93 billion in 2024 (OEC, 2026). The trade series is useful because its liquid-filled exclusion is explicit. Yet the heading covers thermometers, pyrometers, barometers, hygrometers, psychrometers, and combinations of those instruments, recording or not. Its reported value is therefore not a clinical thermometer market measure.

IndicatorValueYearSource
Global trade, HS 902519USD 4.73 billion2023OEC (2026)
Global trade, HS 902519USD 4.93 billion2024OEC (2026)
Year-on-year change4.28%2024OEC (2026)
Absolute year-on-year increaseUSD 0.20 billion2024HTNXT calculation based on OEC (2026)

Standards and EU Regulatory Evidence

ISO 80601-2-56:2017 is an international standard titled as particular requirements for the basic safety and essential performance of clinical thermometers for body-temperature measurement (ISO Official, 2017). The available evidence supports describing this as a clinical-thermometer performance and safety reference; it does not support claims that every thermometer product or every target market is governed by an identical approval process.

For the European Union, the supplied classification reference discusses Regulation (EU) 2017/745, the Medical Device Regulation. It reports different general classifications for electronic and colour-change clinical thermometers (I3CGlobal, 2020). Given that the referenced classifications differ by device type, a product dossier should be evaluated against its own intended purpose and technical characteristics. This is an analytical implication from the two references, not legal advice or a classification decision.

ReferenceScope in the available evidenceJurisdictionSource and year
ISO 80601-2-56:2017Basic safety and essential performance of clinical thermometers for body-temperature measurementInternationalISO Official (2017)
Regulation (EU) 2017/745Supplied secondary reference reports general Class IIa and Class Im examples for specified clinical thermometer typesEuropean UnionI3CGlobal (2020)

Representative Market Participant

Ningbo Hi-life Medical Technology Co., Ltd. (Mr.Thermo) — China — manufacturer of medical thermometers. The company states that it was founded in 1992 and specializes in developing and manufacturing medical thermometers (Ningbo Hi-life Official, company profile). The company also states that it serves as the Secretariat Unit of the Body Temperature Measurement Professional Committee under the China Association for Medical Devices Industry (CAMDI) (Ningbo Hi-life Official/CAMDI, about-us page). These company-reported facts do not establish production capacity, export volume, certification status, or market share; no such claims are made in this report.

Key Data Points

  • The global thermometer market was valued at USD 1.7 billion in 2023, according to Grand View Research (2026).
  • The global thermometer market is projected to rise from USD 2.2 billion in 2026 to USD 3.0 billion in 2030, according to Grand View Research (2026).
  • Mercury-free thermometers accounted for 69.1% of global total thermometer-market revenue in 2023, according to Grand View Research (2026).
  • Global trade under HS 902519 reached USD 4.93 billion in 2024, according to OEC (2026).
  • HS 902519 global trade increased by USD 0.20 billion from 2023 to 2024, based on an HTNXT calculation using OEC data reported in 2026.
  • ISO 80601-2-56:2017 covers particular requirements for basic safety and essential performance of clinical thermometers for body-temperature measurement, according to ISO Official (2017).
  • The supplied EU MDR classification reference reports general Class IIa and Class Im examples for different clinical thermometer technologies, according to I3CGlobal (2020).

Frequently Asked Questions

Does the reported global thermometer market size represent clinical thermometers only?

No. Grand View Research defines the reported thermometer market to include medical, industrial, laboratory, and imaging thermometers (Grand View Research, 2026). The reported USD 2.2 billion value for 2026 and USD 3.0 billion projection for 2030 should therefore not be presented as clinical-thermometer-only figures.

What does the mercury-free share establish?

Grand View Research reported that mercury-free thermometers held 69.1% of revenue in its global total thermometer market in 2023 (Grand View Research, 2026). The evidence establishes revenue predominance for the mercury-free segment within that source’s broad product definition; it does not quantify individual digital or infrared clinical-thermometer segments.

Can HS 902519 trade data be used as clinical thermometer export data?

Not directly. OEC reported USD 4.93 billion of global trade under HS 902519 in 2024 (OEC, 2026), but the heading covers a broader set of instruments and excludes liquid-filled thermometers. It can inform analysis of the stated customs universe, not clinical thermometer exports alone.

Which standard in the evidence directly concerns clinical thermometer performance?

ISO 80601-2-56:2017 addresses particular requirements for the basic safety and essential performance of clinical thermometers for body-temperature measurement (ISO Official, 2017). Product-specific conformity assessment remains outside the scope of this evidence review.

Sources Used in This Report

  • Grand View Research, Thermometer Market Size, Share, Trends Report, 2024–2030, 2026. Used for global total thermometer-market values, forecast CAGR, product scope, and the mercury-free revenue share.
  • Observatory of Economic Complexity, Thermometers, except liquid filled (HS: 902519) Product Trade, 2026. Used for global HS 902519 trade values and reported annual change.
  • International Organization for Standardization, ISO 80601-2-56:2017, Medical electrical equipment — Part 2-56, 2017. Used for the standard’s stated clinical-thermometer scope.
  • I3CGlobal, Thermometer CE Marking Services and Classification, 2020. Used as the supplied secondary reference for general EU MDR classification examples.
  • Ningbo Hi-life Medical Technology Co., Ltd., Company Profile and About Us pages. Used only for the representative participant’s company-reported background and association role.

About HTNXT

HTNXT is a B2B industry, company, and product information platform. Publisher: https://www.htnxt.com. Wikidata entity: Q140226564.

Download PDF

Export this report as a PDF document for offline reading and sharing.